Idea for MRNA: - Contrarian bet - Investors believing that Nu variant will be a boon for Moderna and vaccine stocks. - I think the opposite. Exit for Vaccine pump and dumpers before the bear market. - Either the Nu var is a ruse, and we dont need boosters (bearish MRNA) - Or Nu var is resistant to all vaccines (bearish MRNA) Either way, very cheap to fade it...
technicals showing a possible DTL in the next coming trading sessions.. has been parabolic the past few days prior now and ever since we've been long ;)
Last week ended with sell-offs amid fears about the new extremely contagious COVID 19 Omicron variant. Crude and stock markets suffered. But during this brief rally some shares continued to gain, and it is no wonder that these are the stocks of vaccine producers. Pfizer stocks posted a new all-time high on Friday rising by 6.11% to $54.94. Stocks were...
Not financial advice! With the new corona variant spreading fear all over the world, PFE and MRNA are running. I think it's possible for MRNA to reclaim the bullish channel, aka the Bull-Trap that broke down, when PFE announced the Paxlovid-med. I got in MRNA way to late, now taking a risky trade, since MRNA gaps like crazy, and there's always the chance that...
Pfizer is now outperforming Merck and Moderna stocks after announcing its anti-COVID pill despite its shares not being the best option for investments in the first half of this year. Pfizer stocks gained only 35% since the beginning of this year until mid-August. Moderna stocks were skyrocketed by 375% for the same period. So, undoubtedly Moderna was the...
$MRNA $308 or $300 bounce (If we get below then reclaim these levels, take a position for calls) Price targets: 308->310 300->305 Technical analysis: Bounce off pivot point around 308 area or bounce off psychological level at 300 Rationale: With increasing news of a new virus variant, vaccine stocks are rallying so there is built up potential for more momentum
Hi guys, I think Moderna will go up again and get a trend change up. Today Moderna breaks out of the trenchannel and the rsi has also potential for going up. If the chart goes over the EMAs than it get also from them supported and have a good chance to go up again. what you guys think?
Moderna broke trend to the downside, so long term view is more likely a short rather than long. As illustrated in the chart, I wouldn't short at current prices, but around the red level I have drawn. The trade is invalidated if it closes above the red zone with high volume. If it closes above it but on low volume, it could be a fake out with the following candles...
We took a short on MRNA in the high 300's or so and now Moderna is in the mid 200's. I'm looking for potential gaps to be filled on Moderna to the upside before any further move to the downside. Possiblity is still there for further downside, although this one may try to get a dead cat bounce in here. Targets : 280 340 226 LIS..
In this video: We discuss current Moderna sentiment Aaron Rodgers being un-vaccinated The use of additional tools to measure market sentiment Google Trends as a Lagging Inverse Correlation Indicator Go Pack Go! Link to Pat McAfee Show: youtu.be
✅MODERNA is making a rebound And will soon retest the resistance From where a pullback is likely With the target being the recent low SHORT🔥 ✅Like and subscribe to never miss a new idea!✅
Idea for MRNA: - Good level for reversal. Aug 13 is the capitulation date. - Stop is at 41 degrees. - Gamma squeeze bubble ends with big deflation. TP1: Gap fill 260~ PT 0.5 retrace of move: GLHF - DPT
Pivot on a huge impulse fractal confirmed. We are drawing more and more zigzags from now on. Our goals are shown. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more...
After bullish trend and a distribution phase it is expected that bearish trend would be followed. Short selling would be advised. Entry position mentioned in charts
Moderna broke weekly support making this very vulnerable towards 237-250$/share. Will fall pretty hard in coming days - weeks iMO. Overvalued af in the high 400's nearly cut in half but not quite yet .. currently in puts.
International pharmaceutical giant Merck & Co announced the successful end of its clinical trial of the world’s first oral COVID-19 antiviral drug molnupiravir in the simple form of a pill. The company has claimed that molnupiravir effectively decreases the risk of hospitalization and death of sick individuals who have just contracted the virus or have advanced...
Hello my beauties. I think MRNA has entered a distribution range, as the ST (second test) seemed to be pretty weak, and the price is now showing weakness below the trading range. We are going to wait for further developments in price action and eventually take a trade on the final LPSY. For those of you who like trading ranges, this might be a juicy opportunity....